ASEPSIS-PACK Trademark

Trademark Overview


On Tuesday, January 31, 2012, a trademark application was filed for ASEPSIS-PACK with the United States Patent and Trademark Office. The USPTO has given the ASEPSIS-PACK trademark a serial number of 85530264. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 5, 2019. This trademark is owned by Asepsis Pharmaceuticals Inc.. The ASEPSIS-PACK trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of d...
asepsis-pack

General Information


Serial Number85530264
Word MarkASEPSIS-PACK
Filing DateTuesday, January 31, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 5, 2019
Registration Number4255272
Registration DateTuesday, December 4, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2012

Trademark Statements


Goods and ServicesAnti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 5, 2019
Primary Code005
First Use Anywhere DateTuesday, January 31, 2012
First Use In Commerce DateTuesday, January 31, 2012

Trademark Owner History


Party NameAsepsis Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Stonington, CT 06359

Party NameAsepsis Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Stonington, CT 06359

Party NameAsepsis Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Stonington, CT 06359

Trademark Events


Event DateEvent Description
Friday, July 5, 2019CANCELLED SEC. 8 (6-YR)
Monday, April 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 4, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 4, 2012REGISTERED-PRINCIPAL REGISTER
Saturday, October 27, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, October 26, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 9, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 9, 2012STATEMENT OF USE PROCESSING COMPLETE
Monday, October 1, 2012USE AMENDMENT FILED
Tuesday, October 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 1, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, July 10, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 15, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 12, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 10, 2012ASSIGNED TO LIE
Tuesday, March 20, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 17, 2012ASSIGNED TO EXAMINER
Monday, February 6, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 3, 2012NEW APPLICATION ENTERED IN TRAM